MedTrace Logo

Game to Improve Hearing Health Care Outcomes

NCT02946567 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 159

Last updated 2017-10-05

No results posted yet for this study

Summary

The investigators are studying the educational potential of games, with the goal of developing a game to improve learning and promote healthy hearing behaviors.

The project is looking for adolescents and young adults that play games to share their experience and learning from playing games.

The investigators ask participants to fill out an enrollment form/informed consent, complete surveys on healthy hearing habits, and play a game provided by the project.

This projects aims the development and evaluation of a game to educate teenagers and young adults about noise-induced hearing loss, enhance knowledge about hearing, and promote healthy hearing behaviors with the potential to improve hearing health care.

Conditions

  • Focus of the Study is to Promote Healthy Hearing

Interventions

OTHER

Noisy City information about hearing health care

Participants will play the game Noisy City, which contains information about hearing health care.

OTHER

Generic Game

Participants will play a generic game without any particular information about hearing health care.

Sponsors & Collaborators

  • National Institute on Deafness and Other Communication Disorders (NIDCD)

    collaborator NIH

  • Photozig, Inc.

    lead INDUSTRY

Principal Investigators

  • Bruno Kajiyama, MS · Photozig, Inc.

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
13 Years
Max Age
20 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-09-30
Primary Completion
2017-03-31
Completion
2017-03-31

Countries

  • United States

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02946567 on ClinicalTrials.gov